JNJ

Emergent Biosolutions, Inc. (NYSE: EBS), Johnson & Johnson (NYSE: JNJ) – USA puts Johnson & Johnson in charge of the problem vaccine factory in Baltimore, removes AstraZeneca

US production of the COVID-19 vaccine accelerates dramatically

US vaccine manufacturing for Covid-19 runs ahead

Biden’s White House links with big technology are detailed in new disclosures

Covid-19 Variant Vaccines in Works at Johnson & Johnson

J&J Covid-19 single dose vaccine approved by EU drug regulator

Dow ends up over 32,000 marks for the first time. See how you got there

Covid-19 vaccines targeting multiple strains are underway

The CDC says that fully vaccinated people can meet in small groups without masks

American scientists skeptical of single-dose regimen for Pfizer, Moderna Covid Vaccines

J&J Covid-19 vaccine shipments target states

Stock rises as yield decreases, JNJ vaccine gets authorization